Crocetin (25 and 50 mg/kg, IP, for 15 days) treatment on norepinephrine-induced cardiac hypertrophy, significantly improved myocardial function compared to captopril as a standard drug through increased SOD and GPX activities and decreased lipid peroxidation in the cardiac myocytes. The gene discussed is SOD1; the disease is cardiac hypertrophy.